🇦🇪 Revuforj in United Arab Emirates

Revuforj (REVUMENIB) regulatory status in United Arab Emirates.

Marketing authorisation

MOH

  • Marketing authorisation holder: SYNDAX
  • Status: likely_approved

Revuforj in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United Arab Emirates

Frequently asked questions

Is Revuforj approved in United Arab Emirates?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Revuforj in United Arab Emirates?

SYNDAX holds the UAE marketing authorisation.